Holdings of Janus Henderson Global Life Sciences Fund
JANUS INVESTMENT FUND · Original filing · Compare with another fund · Report an error
- Net assets
- 5.2B $ including 4.6B $ in equities, 87.7 %
- Positions
- 75 in 7 countries
- Top ten
- 39.5 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 499,479 | 459.4M $ | 8.84 % |
| 2 | Johnson & Johnson | 1,550,240 | 378.9M $ | 7.29 % |
| 3 | AstraZeneca PLC | 1,221,946 | 238.6M $ | 4.59 % |
| 4 | AbbVie Inc | 967,983 | 210.5M $ | 4.05 % |
| 5 | UnitedHealth Group Inc | 601,241 | 162.7M $ | 3.13 % |
| 6 | Thermo Fisher Scientific Inc | 265,275 | 130.4M $ | 2.51 % |
| 7 | Praxis Precision Medicines Inc | 394,970 | 127.3M $ | 2.45 % |
| 8 | Abbott Laboratories | 1,212,497 | 124.5M $ | 2.40 % |
| 9 | Bridgebio Pharma Inc | 1,551,141 | 115.2M $ | 2.22 % |
| 10 | Sanofi SA | 1,116,972 | 107.7M $ | 2.07 % |
| 11 | Vertex Pharmaceuticals Inc | 239,922 | 107.1M $ | 2.06 % |
| 12 | Revolution Medicines Inc | 1,088,018 | 105.8M $ | 2.04 % |
| 13 | Intuitive Surgical Inc | 227,319 | 104.8M $ | 2.02 % |
| 14 | HCA Healthcare Inc | 206,592 | 97.8M $ | 1.88 % |
| 15 | Boston Scientific Corp | 1,520,117 | 95.4M $ | 1.84 % |
| 16 | Amgen Inc | 270,089 | 95M $ | 1.83 % |
| 17 | Stryker Corp | 260,843 | 85.7M $ | 1.65 % |
| 18 | Danaher Corp | 448,567 | 85M $ | 1.64 % |
| 19 | Madrigal Pharmaceuticals Inc | 149,195 | 78.1M $ | 1.50 % |
| 20 | CVS Health Corp | 1,071,894 | 77M $ | 1.48 % |
| 21 | Merck & Co Inc | 638,574 | 76.8M $ | 1.48 % |
| 22 | PTC Therapeutics Inc | 1,024,173 | 69.8M $ | 1.34 % |
| 23 | United Therapeutics Corp | 116,721 | 69.2M $ | 1.33 % |
| 24 | McKesson Corp | 79,818 | 69.1M $ | 1.33 % |
| 25 | Gilead Sciences Inc | 471,681 | 65.7M $ | 1.26 % |
| 26 | Globus Medical Inc | 748,604 | 64.5M $ | 1.24 % |
| 27 | Mirum Pharmaceuticals Inc | 685,482 | 63.3M $ | 1.22 % |
| 28 | Vaxcyte Inc | 971,737 | 56.5M $ | 1.09 % |
| 29 | Medtronic PLC | 583,432 | 50.6M $ | 0.97 % |
| 30 | Elevance Health Inc | 165,285 | 48.4M $ | 0.93 % |
| 31 | Dyne Therapeutics Inc | 2,528,224 | 45.8M $ | 0.88 % |
| 32 | Cencora Inc | 139,138 | 43.7M $ | 0.84 % |
| 33 | Travere Therapeutics Inc | 1,432,164 | 42.5M $ | 0.82 % |
| 34 | Lantheus Holdings Inc | 518,786 | 39.3M $ | 0.76 % |
| 35 | Medline Inc | 864,511 | 38.5M $ | 0.74 % |
| 36 | Edwards Lifesciences Corp | 465,579 | 37.3M $ | 0.72 % |
| 37 | Dexcom Inc | 561,491 | 35.3M $ | 0.68 % |
| 38 | Soleno Therapeutics Inc | 987,780 | 33.1M $ | 0.64 % |
| 39 | Apogee Therapeutics Inc | 379,608 | 32M $ | 0.61 % |
| 40 | UCB SA | 104,561 | 31.5M $ | 0.61 % |
| 41 | Becton Dickinson & Co | 181,577 | 28.5M $ | 0.55 % |
| 42 | Glaukos Corp | 264,704 | 28.5M $ | 0.55 % |
| 43 | Ideaya Biosciences Inc | 738,748 | 24.6M $ | 0.47 % |
| 44 | Penumbra Inc | 73,736 | 24.2M $ | 0.47 % |
| 45 | Tarsus Pharmaceuticals Inc | 296,425 | 20.8M $ | 0.40 % |
| 46 | Edgewise Therapeutics Inc | 659,507 | 20.8M $ | 0.40 % |
| 47 | Xenon Pharmaceuticals Inc | 348,546 | 20.3M $ | 0.39 % |
| 48 | Cooper Cos Inc/The | 281,740 | 20.1M $ | 0.39 % |
| 49 | Cogent Biosciences Inc | 498,576 | 19.2M $ | 0.37 % |
| 50 | Biohaven Ltd | 2,220,238 | 18.8M $ | 0.36 % |
| 51 | Regeneron Pharmaceuticals, Inc. | 23,991 | 18.5M $ | 0.36 % |
| 52 | Daiichi Sankyo Co Ltd | 1,047,000 | 18.5M $ | 0.36 % |
| 53 | STERIS PLC | 81,916 | 18.1M $ | 0.35 % |
| 54 | Neurocrine Biosciences Inc | 136,901 | 18M $ | 0.35 % |
| 55 | Protagonist Therapeutics Inc | 160,299 | 16.9M $ | 0.33 % |
| 56 | Scholar Rock Holding Corp | 341,699 | 16.8M $ | 0.32 % |
| 57 | Zoetis Inc | 131,945 | 15.6M $ | 0.30 % |
| 58 | Ardelyx Inc | 2,595,821 | 15.5M $ | 0.30 % |
| 59 | Alnylam Pharmaceuticals Inc | 45,992 | 15.2M $ | 0.29 % |
| 60 | Sotera Health Co | 1,058,022 | 15.2M $ | 0.29 % |
| 61 | Crinetics Pharmaceuticals Inc | 394,286 | 14.3M $ | 0.28 % |
| 62 | HeartFlow Inc | 585,648 | 14.2M $ | 0.27 % |
| 63 | Rhythm Pharmaceuticals Inc | 160,804 | 14M $ | 0.27 % |
| 64 | Nuvalent Inc | 128,313 | 13.1M $ | 0.25 % |
| 65 | Illumina Inc | 102,214 | 12.6M $ | 0.24 % |
| 66 | Insulet Corp | 59,223 | 12.4M $ | 0.24 % |
| 67 | Teleflex Inc | 97,944 | 11.7M $ | 0.23 % |
| 68 | Centene Corp | 340,855 | 11.2M $ | 0.21 % |
| 69 | Janux Therapeutics Inc | 720,074 | 10M $ | 0.19 % |
| 70 | Olema Pharmaceuticals Inc | 669,297 | 10M $ | 0.19 % |
| 71 | Terns Pharmaceuticals Inc | 187,062 | 9.9M $ | 0.19 % |
| 72 | Humana Inc | 52,740 | 9.1M $ | 0.18 % |
| 73 | Immunome Inc | 368,708 | 8.1M $ | 0.16 % |
| 74 | 4D Molecular Therapeutics Inc | 843,751 | 7.9M $ | 0.15 % |
| 75 | Lexeo Therapeutics Inc | 633,486 | 3.6M $ | 0.07 % |
Sector breakdown
- Health care 70.0 %
- Unattributed 30.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 91.3 %
- GBP 5.2 %
- EUR 3.1 %
- JPY 0.4 %
The quoted currency of each line, as declared.
Country breakdown
- United States 90.4 %
- United Kingdom 5.2 %
- France 2.4 %
- Belgium 0.7 %
- Canada 0.4 %
- British Virgin Islands 0.4 %
- Japan 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 69 | 4.1B $ | 90.44 % |
| 2 | United Kingdom | 1 | 238.6M $ | 5.24 % |
| 3 | France | 1 | 107.7M $ | 2.36 % |
| 4 | Belgium | 1 | 31.5M $ | 0.69 % |
| 5 | Canada | 1 | 20.3M $ | 0.44 % |
| 6 | British Virgin Islands | 1 | 18.8M $ | 0.41 % |
| 7 | Japan | 1 | 18.5M $ | 0.41 % |
Cite this page
Titelia. "Holdings of Janus Henderson Global Life Sciences Fund". https://titelia.com/en/funds/S000010494